Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg)
Clinical trial NCT06171490 · COMPLETED
Trial details
- NCT number
- NCT06171490
- Sponsor
- Philip Morris Products S.A.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2024-01-14
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.